| __timestamp | Insmed Incorporated | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 31073000 | 44820000 |
| Thursday, January 1, 2015 | 43216000 | 82080000 |
| Friday, January 1, 2016 | 50679000 | 97130000 |
| Sunday, January 1, 2017 | 79171000 | 121271000 |
| Monday, January 1, 2018 | 168218000 | 153548000 |
| Tuesday, January 1, 2019 | 210796000 | 202541000 |
| Wednesday, January 1, 2020 | 203613000 | 245164000 |
| Friday, January 1, 2021 | 234273000 | 285773000 |
| Saturday, January 1, 2022 | 265784000 | 325998000 |
| Sunday, January 1, 2023 | 344501000 | 332540000 |
Unleashing insights
In the competitive landscape of biotechnology, understanding the financial strategies of leading companies is crucial. Over the past decade, Insmed Incorporated and PTC Therapeutics, Inc. have shown significant growth in their Selling, General, and Administrative (SG&A) expenses, reflecting their strategic investments in operations and market expansion.
From 2014 to 2023, Insmed's SG&A expenses surged by over 1,000%, peaking at approximately $345 million in 2023. This growth underscores Insmed's aggressive push in the biotech sector. Meanwhile, PTC Therapeutics saw a similar upward trajectory, with a 640% increase, reaching around $332 million in the same year.
These figures highlight the intense competition and the substantial financial commitments required to maintain a leading edge in biotechnology. As these companies continue to innovate, their financial strategies will be pivotal in shaping their future success.
Who Optimizes SG&A Costs Better? AstraZeneca PLC or Insmed Incorporated
SG&A Efficiency Analysis: Comparing GSK plc and Insmed Incorporated
Breaking Down SG&A Expenses: Insmed Incorporated vs Sarepta Therapeutics, Inc.
Insmed Incorporated and Corcept Therapeutics Incorporated: SG&A Spending Patterns Compared
Insmed Incorporated or Viking Therapeutics, Inc.: Who Manages SG&A Costs Better?
Insmed Incorporated or Catalyst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Insmed Incorporated vs Dynavax Technologies Corporation
Who Optimizes SG&A Costs Better? Insmed Incorporated or Galapagos NV
SG&A Efficiency Analysis: Comparing Blueprint Medicines Corporation and PTC Therapeutics, Inc.
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs PTC Therapeutics, Inc.
Selling, General, and Administrative Costs: Ionis Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
PTC Therapeutics, Inc. or Veracyte, Inc.: Who Manages SG&A Costs Better?